Skip to Content

Ansell Ltd ADR ANSLY

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Ansell is a leading supplier of protective gloves for use in industrial and healthcare settings, earning approximately 55% of revenue and 65% of operating profit from the healthcare segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2020, Ansell earned 42% of revenue in North America, 33% from Europe, Middle East and Africa, 11% across Asia Pacific and the remaining 7% in Latin America.

678 Victoria Street, Level 3
Richmond, VIC, 3121, Australia
T +61 392707270
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings
Fiscal Year End Jun 30, 2022
Stock Type
Employees 14,159